HIV/AIDS

Future ART Costs

Future ART Costs

Approximately 6.6 million people were receiving anti-retroviral therapy (ART) in low- and middle-income countries at the end of 2010. At current survival rates most of these patients can expect to live another 20 years or more if they continue to receive treatment. Thus the scale-up of treatment today implies a long-term commitment to continue support well into the future. This website provides tools and analysis to improve understanding of the extent of that commitment and is organized around five key questions:

  • What is the lifetime cost of one person starting on ART today?
  • How many people will receive ART and what will be the future costs in low- and middle-income countries for selected parameters?
  • What will be the impact of ART in terms of deaths prevented and new infections averted?
  • How many people will be in need of ART but not receiving treatment?
  • What funding is available for ART and how much more is needed?

Goals Express

Goals Express

Goals Express is intended to assist planners in understanding the effect of funding levels and allocation patterns on HIV/AIDS program impact. The model links funding levels to reductions in HIV incidence and prevalence and improved coverage of treatment, care and support programs using an interactive framework. By linking budget line items to coverage of services, behavior change and prevention of new infections, Goals Direct can help answer key questions such as:

  • How much funding is required to achieve the goals of the strategic plan?
  • What goals can be achieved with the available resources?
  • What is the effect of alternate patterns of resource allocation on the achievement of program goals?

PMTCT

PMTCT

This website provides projections of the future costs and impact of PMTCT in low- and middle-income countries. It uses assumptions about the need for PMTCT, transmission rates and costs for different PMTCT regimens and alternate scenarios to project the number of women on PMTCT, new infections, and associated costs from 2012 to 2017. The default costs and targets found in this website, are global data and thus do not reflect regional or country variation. Users can and should enter country specific information where available.


Unit Cost Repository

Unit Cost Repository

A critical gap in the arsenal needed for HIV/AIDS prevention and treatment planning is a centralized source of intervention costing data that is easily accessible to policy analysts, country officials and implementing organizations. This Unit Cost Repository for HIV Prevention and Treatment Interventions is intended to support the costing of national strategies, assist in Global Fund applications, identify opportunities for sustainability, and be used as an input to economic evaluations. The repository is organized around 5 principal indicators:

  • Intervention
  • Population
  • Country/Region
  • Sector
  • Unit Cost